Clo­vis shut­ters PhII Rubra­ca study af­ter da­ta mon­i­tors turn thumbs down on ef­fi­ca­cy

Still strug­gling to find ways to ex­pand its on­col­o­gy fran­chise for Rubra­ca, Clo­vis qui­et­ly re­vealed af­ter the mar­ket closed Fri­day that it is shut­ter­ing a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER